These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4026249)

  • 1. [Comparative evaluation of the myelotoxic action of rubomycin, adriamycin and carminomycin by their delayed effects in an experiment].
    Fursov SE; Novitskiĭ VV; Fedorenko EN; Gol'dberg ED
    Antibiot Med Biotekhnol; 1985 Apr; 30(4):284-8. PubMed ID: 4026249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of hemopoiesis inhibition and recovery after the administration of carminomycin and rubomycin in an experiment].
    Novitskiĭ VV; Pichugina TV; Gol'dberg ED
    Antibiotiki; 1984 Jun; 29(6):437-41. PubMed ID: 6476806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late effects of the hematotoxic action of antineoplastic antibiotics of the anthracycline group].
    Gol'dberg ED; Novitskiĭ VV; Fursov SE
    Antibiot Khimioter; 1988 Sep; 33(9):671-6. PubMed ID: 3218991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs.
    Syrkin AB; Kiselev AV
    Oncology; 1980; 37 Suppl 1():67-70. PubMed ID: 6935578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reactivity of the blood system in the late periods following administration of the antitumor antibiotic rubomycin].
    Novitskiĭ VV; Fursov SE; Gol'dberg ED
    Biull Eksp Biol Med; 1985 Dec; 100(12):718-9. PubMed ID: 4074877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicity and cumulative properties of carminomycin, rubomycin and adriamycin at different times of use].
    Lichinitser MR; Syrkin AB
    Antibiotiki; 1976 Nov; 21(11):1030-2. PubMed ID: 1020931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of the cytogenetic action of anthracycline-group antitumor antibiotics (daunomycin, doxorubicin and carminomycin)].
    Novitskiĭ VV; Klimova MIu; Gol'dberg ED
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):765-8. PubMed ID: 3789686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colony-forming ability of bone marrow hematopoietic cells in mice with transplanted leukemia during administration of carminomycin].
    Kozinets GI; Ivanova LE; Khanykova OK; Kuznetsova TV; Rudneva NA
    Eksp Onkol; 1984; 6(5):59-62. PubMed ID: 6510345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver mono-oxygenases and the pharmacodynamics of carminomycin and rubomycin].
    Bogush TA; Sitdikova SM
    Antibiotiki; 1984 Jun; 29(6):446-50. PubMed ID: 6476808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the cardiotoxicity of the anthracycline antibiotics, rubomycin, carminomycin and dihydrocarminomycin, in experiments on white mice].
    Shepelevtseva NG; Belova IP; Vertogradova TP; Gol'dberg LE
    Antibiotiki; 1978 Jan; 23(1):78-87. PubMed ID: 623453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative pathomorphological study of the experimental action of carminomycin and rubomycin on the heart].
    Vinogorova GF; Khokhlova MP; Khanykova OK
    Antibiotiki; 1978 Oct; 23(10):931-4. PubMed ID: 708004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the toxicity of carminomycin 13-cyclohexylidenhydrazone].
    Shepelevtseva NG; Vertogradova TP; Belova IP; Gol'dberg LE
    Antibiotiki; 1983 Feb; 28(2):90-5. PubMed ID: 6838184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemopoietic precursor cells during the development of carminomycin resistance].
    Kozinets GI; Ivanova LE; Kuznetsova TV; Khanykova OK
    Eksp Onkol; 1985; 7(1):48-52. PubMed ID: 3979340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reserve potentials of hematopoietic tissue in animals in the period of recovery of the blood morphological composition after carminomycin administration].
    Novitskiĭ VV; Gol'dberg ED; Anyshakova NA
    Antibiotiki; 1981 Dec; 26(12):901-6. PubMed ID: 7325622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin].
    Shepelevtsev NG; Gol'dberg LE; Olsuf'eva EN; Povarov LS
    Antibiotiki; 1982 Jan; 27(1):57-61. PubMed ID: 7059147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Shepelevtseva NG; Vertogradova TP
    Antibiotiki; 1981 Aug; 26(8):620-3. PubMed ID: 6895293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxicity of rubomycin 13-cyclohexylidene hydrazone].
    Stepanova ES; Vertogradova TP; Shevniuk LA; Shepelevtseva NG; Gol'dberg LE
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):42-7. PubMed ID: 3566228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of the myeloinhibitory effect of carminomycin].
    Pichugina TV; Novitskiĭ VV; Gol'dberg ED
    Antibiotiki; 1979 Sep; 24(9):664-8. PubMed ID: 485118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of carminomycin on bone marrow cell proliferative activity and differentiation rate].
    Teterina VI; Pichugina TV; Kolmogorova LA; Gol'dberg ED
    Antibiotiki; 1980 Oct; 25(10):760-4. PubMed ID: 7425595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor activity of doxorubicin in respect to solid tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiot Med Biotekhnol; 1986 Nov; 31(11):866-70. PubMed ID: 3813509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.